| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |